188 related articles for article (PubMed ID: 24312671)
1. Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: a cross-sectional pilot study.
Kim S; Park YM
PLoS One; 2013; 8(12):e82749. PubMed ID: 24312671
[TBL] [Abstract][Full Text] [Related]
2. Serum Prolactin Levels in Patients with Major Depressive Disorder Receiving Selective Serotonin-Reuptake Inhibitor Monotherapy for 3 Months: A Prospective Study.
Park YM
Psychiatry Investig; 2017 May; 14(3):368-371. PubMed ID: 28539956
[TBL] [Abstract][Full Text] [Related]
3. Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine.
Papakostas GI; Miller KK; Petersen T; Sklarsky KG; Hilliker SE; Klibanski A; Fava M
J Clin Psychiatry; 2006 Jun; 67(6):952-7. PubMed ID: 16848655
[TBL] [Abstract][Full Text] [Related]
4. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
5. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W
Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188
[TBL] [Abstract][Full Text] [Related]
6. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
Wu EQ; Yu AP; Lauzon V; Ramakrishnan K; Marynchenko M; Ben-Hamadi R; Blum S; Erder MH
Ann Pharmacother; 2011 Apr; 45(4):441-51. PubMed ID: 21415162
[TBL] [Abstract][Full Text] [Related]
8. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
Strawn JR; Mills JA; Croarkin PE
J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
[No Abstract] [Full Text] [Related]
9. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
[TBL] [Abstract][Full Text] [Related]
11. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
Knorr UB
Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
[TBL] [Abstract][Full Text] [Related]
12. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
13. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram: a review of its use in the management of major depressive disorder in adults.
Garnock-Jones KP; McCormack PL
CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
[TBL] [Abstract][Full Text] [Related]
15. Diminished functional properties of T regulatory cells in major depressive disorder: The influence of selective serotonin reuptake inhibitor.
Jahangard L; Behzad M
J Neuroimmunol; 2020 Jul; 344():577250. PubMed ID: 32344162
[TBL] [Abstract][Full Text] [Related]
16. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder.
Varigonda AL; Jakubovski E; Taylor MJ; Freemantle N; Coughlin C; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2015 Jul; 54(7):557-64. PubMed ID: 26088660
[TBL] [Abstract][Full Text] [Related]
18. [Galactorrhoea and the use of selective serotonin reuptake inhibitors].
Wessels-van Middendorp AM; Timmerman L
Tijdschr Psychiatr; 2006; 48(3):229-34. PubMed ID: 16956087
[TBL] [Abstract][Full Text] [Related]
19. The association between macroprolactin levels and vitamin D status in premenopausal women with macroprolactinemia: a pilot study.
Krysiak R; Kowalska B; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):446-50. PubMed ID: 26179930
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and reproductive manifestations of macroprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]